Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2012
07/05/2012WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
07/05/2012WO2012092411A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092409A2 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012089123A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012089122A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012088682A1 2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
07/05/2012WO2012088680A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012088647A1 Deuterated acid addition salt of sitaliptin
07/05/2012WO2011031816A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172595 Novel process for the synthesis of pemetrexed disodium salt
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172402 Induction of alpha helix conformations in proteins and peptides
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172370 Preparation of crystalline forms of dihydropyrazolopyrimidinone
07/05/2012US20120172366 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
07/05/2012US20120172350 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172349 Therapeutic compounds and compositions
07/05/2012US20120172346 Use of nicotinic acetylcholine receptor alpha 7 activators
07/05/2012US20120172289 Multifunctional glycopeptide antibiotic derivatives for fluorescent imaging and photoactive antimicrobial therapy
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171157 Macrocyclic Inhibitors Of Hepatitis C Virus
07/05/2012CA2822556A1 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2821340A1 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/04/2012EP2471793A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471789A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471787A1 New compounds
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2470548A2 Method for preparing silica particles containing a phthalocyanine derivative, said particles, and uses thereof
07/04/2012EP2470543A1 Visible/nir photodetectors
07/04/2012EP2470542A2 Preparation of sitagliptin and salts thereof
07/04/2012EP2470541A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470540A1 Novel forms of a multicyclic compound
07/04/2012EP2470539A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470538A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470537A2 Heterocyclic compounds as janus kinase inhibitors
07/04/2012EP2470536A1 Methylpyrrolopyrimidinecarboxamides
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470513A1 Macrocyclic hopo chelators
07/04/2012EP2470498A1 Carbocyclic glyt1 receptor antagonists
07/04/2012EP2470183A2 Heterocyclic amide compounds as protein kinase inhibitors
07/04/2012EP2276725B1 New ruthenium complexes as catalysts for metathesis reactions
07/04/2012EP2238142B1 Macrocyclic indoles as hepatitis c virus inhibitors
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012CN102548996A Automated radio synthesis
07/04/2012CN102548995A Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
07/04/2012CN102548994A Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
07/04/2012CN102548993A Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
07/04/2012CN102548991A Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
07/04/2012CN102548973A Mesoionic pesticides
07/04/2012CN102533600A Marine streptomyces/pyranosesquiterpene compound and preparation method and application thereof
07/04/2012CN102532146A Methods for extracting chlorophyll and detecting chlorophyll concentration
07/04/2012CN102532145A Method for synthesizing hydrated dipyridino hexahydro triazine bromide salt
07/04/2012CN102532144A Novel indoleamine-2,3-dioxygenase inhibitor as well as preparation method and application thereof
07/04/2012CN102532143A Cypridina luciferin stabilization composition and method for storing cypridina luciferin
07/04/2012CN102532142A Hydrate of sulfonylurea compound, process for producing same and suspension formulation containing same
07/04/2012CN102532141A (1,2,4)-triazolo-(4,3-b) (1,2,4)-triazine compounds, as well as preparation method and use thereof
07/04/2012CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
07/04/2012CN102531991A Novel multi-amino functionalized ionic liquid and preparation method thereof
07/04/2012CN102060858B Method for simultaneously extracting chlorophyll and protein from red clover processing waste water
07/04/2012CN101973996B Imide biotin intermediate monoester and preparation method and use thereof
07/04/2012CN101960637B Organic electroluminescent device
07/04/2012CN101899046B Method for synthesizing persantine intermediate 2,4,6,8-tetrahydroxy pyrimido[5,4-d] pyrimidine
07/04/2012CN101830903B Aildenafil citrate crystal form O, preparation method and application thereof
07/04/2012CN101781273B Dipeptidylpeptidase IV inhibitor containing guanidyl
07/04/2012CN101717400B Synthesis method of 3,7-dinitro-1,3,5,7-4-azabicyclo[3,3,1]nonane
07/04/2012CN101675061B Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
07/04/2012CN101613356B Quinazoline tetracyclic derivative, preparation method thereof and application thereof in pharmacy
07/04/2012CN101568336B Macrocyclic peptides as hepatitis c virus inhibitors
07/04/2012CN101472927B Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
07/04/2012CN101243050B Pyrazolone derivatives
07/03/2012US8212041 Fused heterocyclic derivatives and methods of use
07/03/2012US8212023 Methods and intermediates for the synthesis of porphyrins
07/03/2012US8211926 Bicyclic pyrazolo-heterocycles
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211899 Artificial nucleic acid bases and their use in base pairing natural nucleic acid bases
07/03/2012US8211883 Topical delivery of phthalocyanines
07/03/2012CA2584757C Halogen substituted benzodiazepine derivatives
07/03/2012CA2518934C Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
07/03/2012CA2518766C Anti-hepatitis c virus agents and anti-hiv agents
06/2012
06/28/2012WO2012088411A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
06/28/2012WO2012087782A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
06/28/2012WO2012087519A1 Compositions and methods for modulating fxr
06/28/2012WO2012086807A1 Novel cyclic amine compound, and process for producing polyurethane resin using same
06/28/2012WO2012085662A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012WO2012085501A1 8 - sulfo - imidazotetrazin- 4 - one compounds and their use as anticancer drug
06/28/2012WO2012085244A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
06/28/2012WO2012085176A1 Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
06/28/2012WO2012085126A1 Oxindolopyrimidine as igf1r receptor inhibitors
06/28/2012WO2012085038A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
06/28/2012WO2012084804A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
06/28/2012WO2012044562A3 Pyrazolopyrimidine pde10 inhibitors
06/28/2012WO2012030170A3 Novel compound acting as a cannabinoid receptor-1 inhibitor
06/28/2012US20120165529 Process for preparing tetrahydrotetraazapentacenes and derivatives
06/28/2012US20120165526 Useful Pharmaceutical Salts of 7- [(3R, 4R) - 3 - Hydroxy -4 - Hydroxymethyl - Pyrrolidin -1- Ylmethyl] -3, 5-Dihydro-Pyrrolo [3, 2-D] Pyrimidin -4-One
06/28/2012US20120165349 Phenyl-Substituted Pyrazolopyrimidines
06/28/2012US20120165348 Novel compounds
06/28/2012US20120165331 Di/tri-aza-spiro-C9-C11alkanes
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 573